Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 6 , Pages 453-457 , November 2009

Delayed Detection of Atrial Fibrillation after Ischemic Stroke

  • Hooman Kamel, MD

      Affiliations

    • Department of Neurology, University of California, San Francisco
  • ,
  • Kennedy R. Lees, MD

      Affiliations

    • Acute Stroke Unit, Gardiner Institute, Western Infirmary, Glasgow, United Kingdom
  • ,
  • Patrick D. Lyden, MD

      Affiliations

    • Departments of Neurology, San Diego Veterans Administration Medical Center, California
    • University of California, San Diego
  • ,
  • Philip A. Teal, MD

      Affiliations

    • Division of Neurology, University of British Columbia, Vancouver, Canada
  • ,
  • Ashfaq Shuaib, MD

      Affiliations

    • Division of Neurology, University of Alberta, Edmonton, Canada
  • ,
  • Myzoon Ali, MRes

      Affiliations

    • Acute Stroke Unit, Gardiner Institute, Western Infirmary, Glasgow, United Kingdom
  • ,
  • S. Claiborne Johnston, MD, PhD

      Affiliations

    • Department of Neurology, University of California, San Francisco
    • Corresponding Author InformationAddress correspondence to S. Claiborne Johnston, MD, PhD, 505 Parnassus Ave, Box 0114, San Francisco, CA 94143.
  • ,
  • Virtual International Stroke Trials Archive Investigators

Received 13 December 2008 ,Revised 26 January 2009 ,Accepted 30 January 2009.

References 

  1. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial. JAMA. 1998;279:1265–1272
  2. Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: Incidence, recurrence, and long-term survival in ischemic stroke subtypes; a population-based study. Stroke. 2001;32:2735–2740
  3. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: The NINCDS stroke data bank. Ann Neurol. 1989;25:382–390
  4. Sandercock P, Bamford J, Dennis M, et al. Atrial fibrillation and stroke: Prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project). BMJ. 1992;305:1460–1465
  5. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Atrial Fibrillation Investigators. Arch Intern Med. 1994;154:1449–1457
  6. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups; The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655–1711
  7. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet. 1993;342:1255–1262
  8. Chen EH, Hollander JE. When do patients need admission to a telemetry bed?. J Emerg Med. 2007;33:53–60
  9. Saxena R, Koudstaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst Rev. 2004;Issue 2. Art. No.: CD000185. DOI: 10.1002/14651858. CD000185.pub2
  10. Schaer BA, Zellweger MJ, Cron TA, et al. Value of routine Holter monitoring for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemic events. Stroke. 2004;35:e68–e70
  11. Jabaudon D, Sztajzel J, Sievert K, et al. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004;35:1647–1651
  12. Barthelemy JC, Feasson-Gerard S, Garnier P, et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol. 2003;8:194–199
  13. Tayal AH, Tian M, Kelly KM, et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008;71:1696–1701
  14. Mikolich JR, Jacobs WC, Fletcher GF. Cardiac arrhythmias in patients with acute cerebrovascular accidents. JAMA. 1981;246:1314–1317
  15. Schuchert A, Behrens G, Meinertz T. Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke. Pacing Clin Electrophysiol. 1999;22:1082–1084
  16. Koudstaal P, van Gijn J, Klootwijk APJ, et al. Holter monitoring in patients with transient and focal ischemic attacks of the brain. Stroke. 1986;17:192–195
  17. Liao J, Khalid Z, Scallan C, et al. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: A systematic review. Stroke. 2007;38:2935–2940
  18. Shuaib A, Lees KR, Lyden P, et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med. 2007;357:562–571
  19. Lees KR, Zivin JA, Ashwood T, et al. NXY-059 for acute ischemic stroke. N Engl J Med. 2006;354:588–600
  20. Lyden P, Shuaib A, Ng K, et al. Clomethiazole acute stroke study in ischemic stroke (CLASS-I): Final results. Stroke. 2002;33:122–128
  21. Ali M, Bath PM, Curram J, et al. The Virtual International Stroke Trials Archive. Stroke. 2007;38:1905–1910
  22. Teal P, Lyden P, Kaste M, Davis S, et al. Effects of repinotan in patients with acute ischemic stroke: Phase IIb modified randomized exposure controlled trial (mRECT). Oral presentation at the XIV European Stroke Conference, May 28, 2005; Bologna, Italy.
  23. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham heart study. JAMA. 1994;271:840–844
  24. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics–2006 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2006;113:e85–e151
  25. The Dutch TIA Trial Study Group. Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke. Stroke. 1993;24:527–531

 Supported by the Larry L. Hillblom Foundation.

PII: S1052-3057(09)00031-7

doi: 10.1016/j.jstrokecerebrovasdis.2009.01.012

Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 6 , Pages 453-457 , November 2009